A model to estimate survival in ambulatory patients with hepatocellular carcinoma: can it predict the natural course of hepatocellular carcinoma?

Several hepatocellular carcinoma (HCC) staging systems are available including the newly developed staging system, the Model to Estimate Survival in Ambulatory HCC patients (MESIAH); however, whether these staging systems could predict the natural course of HCC is largely unknown.

http://ift.tt/2v8138m